These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


317 related items for PubMed ID: 6326103

  • 21. Analysis of human promyelocytic leukemia cell (HL60) variants insensitive to phorbol ester tumor promoters.
    Mascioli DW, Estensen RD.
    Cancer Res; 1984 Aug; 44(8):3280-5. PubMed ID: 6331641
    [Abstract] [Full Text] [Related]

  • 22. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
    Colburn NH, Gindhart TD, Hegamyer GA, Blumberg PM, Delclos KB, Magun BE, Lockyer J.
    Cancer Res; 1982 Aug; 42(8):3093-7. PubMed ID: 6284358
    [Abstract] [Full Text] [Related]

  • 23. Modulation of globin gene expression by a tumor promoter during induced differentiation of Friend erythroleukemic cells.
    Shaul Y, Ginzburg I, Aviv H.
    Eur J Biochem; 1981 Mar; 114(3):591-5. PubMed ID: 6113141
    [Abstract] [Full Text] [Related]

  • 24. Biological responsiveness to the phorbol esters and specific binding of [3H]phorbol 12,13-dibutyrate in the nematode Caenorhabditis elegans, a manipulable genetic system.
    Lew KK, Chritton S, Blumberg PM.
    Teratog Carcinog Mutagen; 1982 Mar; 2(1):19-30. PubMed ID: 6122277
    [Abstract] [Full Text] [Related]

  • 25. Characterization of specific binding of [3H]phorbol 12,13-dibutyrate and [3H]phorbol 12-myristate 13-acetate to mouse brain.
    Dunphy WG, Delclos KB, Blumberg PM.
    Cancer Res; 1980 Oct; 40(10):3635-41. PubMed ID: 7438048
    [Abstract] [Full Text] [Related]

  • 26. Inhibition by bryostatin 1 of the phorbol ester-induced blockage of differentiation in hexamethylene bisacetamide-treated Friend erythroleukemia cells.
    Dell'Aquila ML, Nguyen HT, Herald CL, Pettit GR, Blumberg PM.
    Cancer Res; 1987 Nov 15; 47(22):6006-9. PubMed ID: 3478136
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of epidermal growth factor binding to mouse embryonal carcinoma cells by phorbol esters mediated by specific phorbol ester receptors.
    Salomon DS.
    J Biol Chem; 1981 Aug 10; 256(15):7958-66. PubMed ID: 6267031
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Expression of erythroid differentiation and terminal cell division in induced Friend leukemia cells.
    Gambari R, Marks PA, Rifkind RA, Farace M, Fantoni A.
    Acta Biol Med Ger; 1981 Aug 10; 40(4-5):511-8. PubMed ID: 7315096
    [Abstract] [Full Text] [Related]

  • 30. Hexamethylenebisacetamide-mediated induction of murine erythroleukemia cells: relationship between expression of beta major and beta minor globin genes, globin mRNA synthesis and commitment to erythroid differentiation.
    Gambari R.
    Biochem Int; 1983 Oct 10; 7(4):471-80. PubMed ID: 6679742
    [Abstract] [Full Text] [Related]

  • 31. Tumor promoters inhibit spontaneous and induced differentiation of murine erythroleukemia cells in culture.
    Yamasaki H, Fibach E, Nudel U, Weinstein IB, Rifkind RA, Marks PA.
    Proc Natl Acad Sci U S A; 1977 Aug 10; 74(8):3451-5. PubMed ID: 269404
    [Abstract] [Full Text] [Related]

  • 32. Effects of cytochrome P1-450 inducers on the cell-surface receptors for epidermal growth factor, phorbol 12,13-dibutyrate, or insulin of cultured mouse hepatoma cells.
    Kärenlampi SO, Eisen HJ, Hankinson O, Nebert DW.
    J Biol Chem; 1983 Sep 10; 258(17):10378-83. PubMed ID: 6309801
    [Abstract] [Full Text] [Related]

  • 33. Association of phorbol ester receptor down modulation with a cryptic receptor state.
    Jaken S, Feldman H, Blumberg PM, Tashjian AH.
    Cancer Res; 1983 Dec 10; 43(12 Pt 1):5795-800. PubMed ID: 6315217
    [Abstract] [Full Text] [Related]

  • 34. Diversity of nuclear phorbol ester tumor promoter receptors in mouse liver: evidence for two classes of binding sites.
    Perrella FW, Bussell PA, Boutwell RK.
    Biochem Biophys Res Commun; 1982 Oct 29; 108(4):1722-7. PubMed ID: 6295390
    [No Abstract] [Full Text] [Related]

  • 35. Characterization of a specific phorbol ester aporeceptor in mouse brain cytosol.
    Leach KL, James ML, Blumberg PM.
    Proc Natl Acad Sci U S A; 1983 Jul 29; 80(14):4208-12. PubMed ID: 6308606
    [Abstract] [Full Text] [Related]

  • 36. Glucocorticoid-mediated increases in glycerol phosphate dehydrogenase activity is inhibited by the phorbol ester tumor promoters.
    Bressler JP, Weingarten D, Kornblith PL.
    J Neurochem; 1985 Oct 29; 45(4):1268-72. PubMed ID: 3861770
    [Abstract] [Full Text] [Related]

  • 37. Tumor promoter binding to rat mammary cell cultures: role of receptors in the inhibition of dome formation.
    Sonnenberg A, Dulbecco R, Okada S.
    Cancer Res; 1983 Mar 29; 43(3):1059-65. PubMed ID: 6297718
    [Abstract] [Full Text] [Related]

  • 38. Competitive inhibition by diacylglycerol of specific phorbol ester binding.
    Sharkey NA, Leach KL, Blumberg PM.
    Proc Natl Acad Sci U S A; 1984 Jan 29; 81(2):607-10. PubMed ID: 6320198
    [Abstract] [Full Text] [Related]

  • 39. Differential effect of tumor promoters on phorbol-ester-receptor binding and membrane fluorescence anisotropy in C3H 10T 1/2 cells.
    Tran PL, Castagna M, Sala M, Vassent G, Horowitz AD, Schachter D, Weinstein LB.
    Eur J Biochem; 1983 Jan 17; 130(1):155-60. PubMed ID: 6297894
    [No Abstract] [Full Text] [Related]

  • 40. Binding of phorbol dibutyrate and epidermal growth factor to cultured human epidermal cells.
    Greenebaum E, Nicolaides M, Eisinger M, Vogel RH, Weinstein IB.
    J Natl Cancer Inst; 1983 Mar 17; 70(3):435-41. PubMed ID: 6300498
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.